Bafilomycin A1 is a macrolide antibiotic that primarily functions as a specific inhibitor of vacuolar-type H+-ATPases (V-ATPases). These enzymes are responsible for acidifying various intracellular compartments, which is crucial for several cellular processes, including protein degradation, receptor-mediated endocytosis, and autophagy.